A hand holding a lens with a medical journal article in the background. The words Donor MUD, Age per 10 years, Sex female and donor sex female are in focus.

The Cell Therapy Lens

Viewing transplant and cell therapy through a wider clinical lens—bringing data, perspective and practice into focus for hematology/oncology and transplant clinicians.
  • Kaplan-Meier survival curves showing overall survival (OS) probability over 12 months for 268 subjects in the ACCESS clinical trial. The analysis compares outcomes for recipients of 7/8 HLA matched grafts (light blue line, n=183) and <7/8 HLA matched grafts (purple line, n=85). At 1 year, the 7/8 cohort OS is 79% and the <7/8 cohort OS is 86%. Data presented by Al Malki et al., at ASH 2025.

    What the data now shows about MMUD HCT

    Steven Devine, MD • 10 min read
    April 24, 2026
    Read more
  • Line graph showing the rise of haplo and MMUD transplants in the U.S. from 2014–2024, with key clinical trial milestones marked.

    Caring for patients after MMUD HCT is more familiar than you think

    Heather Stefanski, MD, PhD • 6 min read
    Oct. 26, 2026
    Read more